| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.20B | +17.5% |
| Gross profit | ¥0.12B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.05B | +25.2% |
| Gross margin | 61.9% | Net margin 23.9% |
| Revenue Q/Q | -5.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 38.1% |
| R&D | ¥0.02B | 10.3% |
| SG&A | ¥0.05B | 23.9% |
| Tax & other | ¥0.01B | 3.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
秋田微 ・ 南极光 ・ 创识科技 ・ 易瑞生物 ・ 春晖智控 ・ 曼卡龙 ・ 恒而达 ・ 德必集团 ・ 冠中生态 ・ 奥雅股份 ・ 德固特 ・ 博硕科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies